{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T17:12:56Z","timestamp":1778433176111,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jad.2025.01.134","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T03:03:49Z","timestamp":1738206229000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clinical characteristics and potential pathology of Moyamoya disease combined with psychiatric disorders in Chinese population - A cross-sectional study"],"prefix":"10.1016","volume":"381","author":[{"given":"Lei","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eryong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.01.134_bb0005","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3109\/14767058.2013.858685","article-title":"Neuropsychiatric manifestations of latent toxoplasmosis on mothers and their offspring","volume":"27","author":"Abdoli","year":"2014","journal-title":"The Journal of Maternal-Fetal & Neonatal Medicine: The Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet."},{"key":"10.1016\/j.jad.2025.01.134_bb0010","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1161\/STROKEAHA.113.004273","article-title":"Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study","volume":"45","author":"Ahn","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/j.jad.2025.01.134_bb0015","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2147\/NDT.S402375","article-title":"Current understanding of Moyamoya disease (MMD) and associated neuropsychiatric outcomes","volume":"19","author":"Antonov","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2025.01.134_bb0020","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.molmed.2022.08.009","article-title":"Moyamoya disease emerging as an immune-related angiopathy","volume":"28","author":"Asselman","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jad.2025.01.134_bb0025","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/jnnp.2007.130666","article-title":"Novel epidemiological features of moyamoya disease","volume":"79","author":"Baba","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.134_bb0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1440-1819.2011.02317.x","article-title":"Mood disorder in association with moyamoya disease","volume":"66","author":"Behere","year":"2012","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2025.01.134_bb0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-319-73739-3_13","article-title":"Incidence of Moyamoya disease in Denmark: a population-based register study","volume":"129","author":"Birkeland","year":"2018","journal-title":"Acta Neurochir. Suppl."},{"key":"10.1016\/j.jad.2025.01.134_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105136","article-title":"Molecular mechanisms of psychiatric diseases","volume":"146","author":"Blokhin","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jad.2025.01.134_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1101612","article-title":"Bioinformatics analysis reveals the landscape of immune cell infiltration and novel immune-related biomarkers in moyamoya disease","volume":"14","author":"Cao","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.jad.2025.01.134_bb0050","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881120908016","article-title":"Efficacy and cognitive effect of sarcosine (N-methylglycine) in patients with schizophrenia: a systematic review and meta-analysis of double-blind randomised controlled trials","volume":"34","author":"Chang","year":"2020","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1016\/j.jad.2025.01.134_bb0055","article-title":"Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders","volume":"13","author":"Chen","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.jad.2025.01.134_bb0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2307\/2136404","article-title":"A global measure of perceived stress","volume":"24","author":"Cohen","year":"1983","journal-title":"J. Health Soc. Behav."},{"key":"10.1016\/j.jad.2025.01.134_bb0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/STROKEAHA.117.017430","article-title":"Novel susceptibility loci for Moyamoya disease revealed by a genome-wide association study","volume":"49","author":"Duan","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.jad.2025.01.134_bb0070","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2174\/1570159X15666171123201142","article-title":"Imaging the role of inflammation in mood and anxiety-related disorders","volume":"16","author":"Felger","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.jad.2025.01.134_bb0075","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2176\/jns-nmc.2021-0382","article-title":"2021 Japanese guidelines for the management of Moyamoya disease: guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society","volume":"62","author":"Fujimura","year":"2022","journal-title":"Neurol. Med. Chir."},{"key":"10.1016\/j.jad.2025.01.134_bb0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jad.2020.12.129","article-title":"Validation of the 7-item Generalized Anxiety Disorder scale (GAD-7) as a screening tool for anxiety among pregnant Chinese women","volume":"282","author":"Gong","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"Suppl. 2","key":"10.1016\/j.jad.2025.01.134_bb0085","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0303-8467(97)00037-1","article-title":"A survey of moyamoya disease in Hawaii","volume":"99","author":"Graham","year":"1997","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jad.2025.01.134_bb0090","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s10143-021-01660-9","article-title":"Quality of life impairment in adult Moyamoya patients-preoperative neuropsychological assessment and correlation to MRI and H(2)(15)O PET findings","volume":"45","author":"Haas","year":"2022","journal-title":"Neurosurg. Rev."},{"key":"10.1016\/j.jad.2025.01.134_bb0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jad.2022.04.031","article-title":"Poor sleep quality, vitamin D deficiency and depression in the stroke population: a cohort study","volume":"308","author":"He","year":"2022","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.01.134_bb0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1507\/endocrj.EJ22-0319","article-title":"Clinical features of moyamoya disease with Graves\u2019 disease: a retrospective study of 394,422 patients with thyroid disease","volume":"70","author":"Hiruma","year":"2023","journal-title":"Endocr. J."},{"key":"10.1016\/j.jad.2025.01.134_bb0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12888-020-02520-4","article-title":"Psychometric properties of the perceived stress scale in a community sample of Chinese","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2025.01.134_bb0110","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1474-4422(22)00165-X","article-title":"Moyamoya disease: diagnosis and interventions","volume":"21","author":"Ihara","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jad.2025.01.134_bb0115","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1086\/302243","article-title":"Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26","volume":"64","author":"Ikeda","year":"1999","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jad.2025.01.134_bb0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/088307380001500307","article-title":"Linkage analysis of moyamoya disease on chromosome 6","volume":"15","author":"Inoue","year":"2000","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jad.2025.01.134_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2024.108403","article-title":"Routine screening serum tests to detect underlying thyroid and autoimmune diseases in patients with moyamoya disease","volume":"243","author":"Ito","year":"2024","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jad.2025.01.134_bb0130","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/jhg.2010.132","article-title":"A genome-wide association study identifies RNF213 as the first Moyamoya disease gene","volume":"56","author":"Kamada","year":"2011","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.jad.2025.01.134_bb0135","doi-asserted-by":"crossref","first-page":"E943","DOI":"10.1093\/neuros\/nyz176","article-title":"Brain structure, connectivity, and cognitive changes following revascularization surgery in adult Moyamoya disease","volume":"85","author":"Kazumata","year":"2019","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jad.2025.01.134_bb0140","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/STROKEAHA.109.562264","article-title":"Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study","volume":"41","author":"Kim","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.jad.2025.01.134_bb0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s007870050096","article-title":"Moyamoya disease in a 12-year-old Caucasian boy presenting with acute transient psychosis","volume":"8","author":"Klasen","year":"1999","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.134_bb0150","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/jnnp-2011-301387","article-title":"Regional differences in incidence and patient characteristics of moyamoya disease: a systematic review","volume":"83","author":"Kleinloog","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.134_bb0155","article-title":"Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis","volume":"365","author":"Levis","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1016\/j.jad.2025.01.134_bb0160","article-title":"Identification of lysosome-related hub genes as potential biomarkers and immune infiltrations of moyamoya disease by multiple bioinformatics methods and machine-learning strategies","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jad.2025.01.134_bb0165","article-title":"Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development","volume":"6","author":"Liu","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.jad.2025.01.134_bb0170","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2269368","article-title":"Association between systemic immune-inflammatory markers and the risk of moyamoya disease: a case-control study","volume":"55","author":"Liu","year":"2023","journal-title":"Ann. Med."},{"key":"10.1016\/j.jad.2025.01.134_bb0175","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1017\/S1355617703950132","article-title":"Moyamoya disease in a patient with schizophrenia","volume":"9","author":"Lubman","year":"2003","journal-title":"Journal of the International Neuropsychological Society: JINS"},{"key":"10.1016\/j.jad.2025.01.134_bb0180","doi-asserted-by":"crossref","DOI":"10.4088\/PCC.21m03157","article-title":"Burden of psychiatric disorders in Moyamoya disease: a national inpatient perspective from 2007-2014","volume":"24","author":"Mansuri","year":"2022","journal-title":"The Primary Care Companion for CNS disorders"},{"key":"10.1016\/j.jad.2025.01.134_bb0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12975-021-00940-2","article-title":"The genetic basis of Moyamoya disease","volume":"13","author":"Mertens","year":"2022","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.jad.2025.01.134_bb0190","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.clineuro.2009.11.009","article-title":"Epidemiological and clinical features of Moyamoya disease in Nanjing, China","volume":"112","author":"Miao","year":"2010","journal-title":"Clinical Neurology and Neurosurgery"},{"key":"10.1016\/j.jad.2025.01.134_bb0195","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jad.2011.03.052","article-title":"Vascular and extravascular immunoreactivity for intercellular adhesion molecule 1 in the orbitofrontal cortex of subjects with major depression: age-dependent changes","volume":"132","author":"Miguel-Hidalgo","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.01.134_bb0200","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4103\/0976-3147.176198","article-title":"Neuropsychiatric manifestations in a child with moyamoya disease","volume":"7","author":"Mohapatra","year":"2016","journal-title":"Journal of Neurosciences in Rural Practice"},{"key":"10.1016\/j.jad.2025.01.134_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106509","article-title":"Lack of association between seropositivity of vasculopathy-related viruses and moyamoya disease","volume":"31","author":"Nakamura","year":"2022","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jad.2025.01.134_bb0210","article-title":"Sarcosine may induce EGF production or inhibit the decline in EGF concentrations in patients with chronic schizophrenia (results of the PULSAR study)","volume":"16","author":"Pawlak","year":"2023","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.jad.2025.01.134_bb0215","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/1354750X.2019.1615124","article-title":"Quantitative analysis of sarcosine with special emphasis on biosensors: a review","volume":"24","author":"Pundir","year":"2019","journal-title":"Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals"},{"key":"10.1016\/j.jad.2025.01.134_bb0220","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3174\/ajnr.A6392","article-title":"MR diffusional kurtosis imaging-based assessment of brain microstructural changes in patients with Moyamoya disease before and after revascularization","volume":"41","author":"Qiao","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.jad.2025.01.134_bb0225","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1176\/appi.ajp.2018.18040404","article-title":"Psychiatric comorbidity in Moyamoya disease and preliminary guidelines for treatment","volume":"176","author":"Richards","year":"2019","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.01.134_bb0230","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s10038-004-0143-6","article-title":"A novel susceptibility locus for moyamoya disease on chromosome 8q23","volume":"49","author":"Sakurai","year":"2004","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.jad.2025.01.134_bb0235","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/0271678X221140349","article-title":"Association of cognitive function and hypoperfusion in Moyamoya disease patients without stroke","volume":"43","author":"Shen","year":"2023","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"key":"10.1016\/j.jad.2025.01.134_bb0240","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archneur.1969.00480090076012","article-title":"Cerebrovascular \u201cmoyamoya\u201d disease. Disease showing abnormal net-like vessels in base of brain","volume":"20","author":"Suzuki","year":"1969","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jad.2025.01.134_bb0245","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1001\/jama.2022.22744","article-title":"Anxiety disorders: a review","volume":"328","author":"Szuhany","year":"2022","journal-title":"Jama"},{"issue":"Suppl. 2","key":"10.1016\/j.jad.2025.01.134_bb0250","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1016\/S0303-8467(97)00049-8","article-title":"Studies on cytomegalovirus and Epstein-Barr virus infection in moyamoya disease","volume":"99","author":"Tanigawara","year":"1997","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jad.2025.01.134_bb0255","first-page":"188","article-title":"Moyamoya disease (presenting as schizophrenia)","volume":"23","author":"TB","year":"1981","journal-title":"Indian J. Psychiatry."},{"key":"10.1016\/j.jad.2025.01.134_bb0260","doi-asserted-by":"crossref","DOI":"10.3171\/foc.1998.5.5.4","article-title":"Moyamoya disease in the midwestern United States","volume":"5","author":"Wetjen","year":"1998","journal-title":"Neurosurg. Focus"},{"issue":"Suppl. 2","key":"10.1016\/j.jad.2025.01.134_bb0265","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1016\/S0303-8467(97)00048-6","article-title":"The relationship between moyamoya disease and bacterial infection","volume":"99","author":"Yamada","year":"1997","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.jad.2025.01.134_bb0270","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/nhs.12729","article-title":"Stress and mood of adults with moyamoya disease: a cross-sectional study","volume":"22","author":"Yang","year":"2020","journal-title":"Nurs. Health Sci."},{"key":"10.1016\/j.jad.2025.01.134_bb0275","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/1570159X19666210716114016","article-title":"Progression in moyamoya disease: clinical features, neuroimaging evaluation, and treatment","volume":"20","author":"Zhang","year":"2022","journal-title":"Curr. Neuropharmacol."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725001557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725001557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:47:30Z","timestamp":1778042850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725001557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":55,"alternative-id":["S0165032725001557"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.01.134","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and potential pathology of Moyamoya disease combined with psychiatric disorders in Chinese population - A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.01.134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}